Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

White Paper

Can Cinderella save us?

Antibiotic resistance to lead to millions of deaths

UK publishes first progress report for antimicrobial resistance strategy

- PMLiVE

UPDATE: Merck to acquire Cubist for $8.4bn

Will expand company's presence in antibiotics

Can Cinderella save us?

NICE wants responsible use of antibiotics in pneumonia

Drugs often prescribed to wrong patients

EU flag

EU consortium focuses on antibiotic ‘husbandry’

IMI-backed group to research ways to tackle antimicrobial resistance

- PMLiVE

Charity forms to tackle resistance to antibiotics

Antibiotic Research UK hopes to develop new drug in dive years

National Institute for Health and Care Excellence NICE logo

NICE working to tackle antimicrobial resistance

Two guidelines in development to improve NHS use of antibiotic drugs

- PMLiVE

Cubist launches Zurich base

US antibiotic company expands into Europe

- PMLiVE

EMA accepts Cubist antibiotic for review

Follows FDA priority review for ceftolozane/ tazobactam

- PMLiVE

FDA approves antibacterial skin drug Orbactiv

US regulator authorises Medicines Company's treatment for ABSSSI

UK flag

Antimicrobial resistance priority for new UK science minister

Greg Clark announces collaboration led by Medical Research Council

UK flag

UK healthcare professionals urged to say ‘no’ to antibiotics

Royal Colleges issues joint statement to members warning of antimicrobial resistance

UK flag

Pharma industry backs UK antibiotics plan

GSK and ABPI back David Cameron’s call for global action on antimicrobial resistance

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links